Search results
PTC Therapeutics' (PTCT) Rare Disease Drug Fails in Study
Zacks via Yahoo Finance· 1 year agoPTC Therapeutics' (PTCT) vatiquinone did not achieve its primary endpoint in a late-stage study in...
News Flash: Analysts Just Made A Notable Upgrade To Their PTC Therapeutics, Inc. (NASDAQ:PTCT)...
Simply Wall St. via Yahoo Finance· 4 weeks agoPTC Therapeutics, Inc. (NASDAQ:PTCT) shareholders will have a reason to smile today, with the...
PTC Therapeutics' Barrage Of Bad News Is Good News For Rival Reata Pharmaceuticals — Here's Why
Investor's Business Daily· 1 year agoPTC stock plummeted Wednesday and gave its closest rival a boost after the company's treatment for a...
PTC Therapeutics Stock Sees IBD RS Rating Climb To 72
Investor's Business Daily· 2 months agoPTC Therapeutics stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday,...
PTC Therapeutics (PTCT) Halts Huntington's Disease Study in US
Zacks via Yahoo Finance· 2 years agoThe FDA requests additional data to allow PTC Therapeutics (PTCT) to continue enrollment in its...
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 8 months agoPTC Therapeutics, Inc. (NASDAQ:PTCT) Q3 2023 Earnings Call Transcript October 29, 2023 Operator:...
The Zacks Analyst Blog Highlights Bristol Myers, PTC Therapeutics, Beam Therapeutics and BioMarin...
Zacks via Yahoo Finance· 8 months agoFor Immediate Release Chicago, IL – October 27, 2023 – Zacks.com announces the list of stocks...
PTC Therapeutics (PTCT) Down on Negative CHMP Opinion for DMD Drug
Zacks via Yahoo Finance· 9 months agoPTC Therapeutics (PTCT) plunges on negative opinion from the Committee for Medicinal Products for...
PTC Therapeutics (PTCT) Lost 16% in Q2
Insider Monkey via Yahoo Finance· 9 months agoTimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter investor letter. A...
PTC to sell spinal muscular atrophy drug royalties for $1B
BioPharma Dive via Yahoo Finance· 8 months agoDive Brief: PTC Therapeutics has agreed to sell a big chunk of its remaining royalty stream from the...